๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Comparative study on three chemotherapeutic regimens for the treatment of advanced epithelial ovarian cancer

โœ Scribed by Changyu, Wang ;Meijiao, Gu ;Shixuan, Wang ;Ding, Ma

Publisher
Springer-Verlag
Year
2000
Tongue
English
Weight
181 KB
Volume
20
Category
Article
ISSN
0257-716X

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Chemotherapy for advanced head and neck
Chemotherapy for advanced head and neck cancer with the combination adriamycin, cyclophosphamide, and cis-diamminedichloroplatinum (II): Preliminary assessment of a one-day vs. three-day drug regimen
โœ Edward T. Creagan; Thomas R. Fleming; John H. Edmonson; James N. Ingle; John E. ๐Ÿ“‚ Article ๐Ÿ“… 1981 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 294 KB ๐Ÿ‘ 3 views

Fourteen patients with advanced head and neck carcinomas received a monthly intravenous regimen of Adriamycin, 40 mg/m2, day 1; cyclophosphamide, 400 mg/m2, day 3; and cis-diamminedichloroplatinum, 20 mg/m2/1 hour, days 1-3 (CAP-3). A regression rate of only 7% (0112 squamous cell carcinomas; 112 ad

A dose-intensive, cyclophosphamide-based
A dose-intensive, cyclophosphamide-based regimen for the treatment of recurrent/Progressive or advanced solid tumors of childhood : A report from the Australia and New Zealand Children's Cancer Study Group
โœ Paul A. Carpenter; Les White; Geoffrey B. McCowage; Vimala Nayanar; Ian Toogood; ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 130 KB ๐Ÿ‘ 3 views

promising salvage regimen. Continued accrual of patients and increased duration of follow-up has resulted in substantial experience with VETOPEC.